Lung cancer is among the most prevalently occurring carcinomas worldwide, and reducing lung cancer mortality depends on early detection, diagnosis, and treatment. Given the rapid development of molecular biology and modern techniques for diagnosis and treatment, the study of serum tumor markers has gained extensive application in early diagnosis, treatment effect monitoring, and prognosis evaluation. Serum tumor markers possess the advantages of easy detection, noninvasive operation, and cost-effectiveness. This article reviews the progress in the study of serum tumor markers of lung cancer.
Wenjie Qi, Xuechang Li, Jingbo Kang. Advances in the study of serum tumor markers of lung cancer. Journal of cancer research and therapeutics. 2014 Nov;10 Suppl:C95-C101
PMID: 25450292
View Full Text